Adani Enterprises' Rs 20,000-crore follow-on public offering (FPO) sent shares southwards in Thursday's intra-day trade, as they slumped over 4 per cent and hit...
India’s largest drugmaker by market share in the domestic pharmaceutical (pharma) market has stepped up its game in the US dermatology space with the acquisition of...
